

Mondelez vs Colgate-Palmolive
Global snacks and confectionery leader with strong brands vs Global oral care and household products leader. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Mondelez International sells snacks and confections across dozens of countries, using its global distribution network and beloved brands like Oreo and Cadbury to push volume while raising prices faster than consumers walk away. Colgate-Palmolive sells oral care, personal care, and home cleaning products in nearly every country on earth, relying on category leadership and a relentless focus on emerging market growth to sustain its premium valuation. Both are classic consumer staples multinationals that use pricing power and distribution advantages to generate steady earnings growth through economic cycles. Mondelez vs Colgate-Palmolive pits two global consumer giants against each other on organic revenue growth, margin expansion potential, dividend history, and which company has the stronger runway to compound earnings from its emerging market exposure over the next decade.
Mondelez International sells snacks and confections across dozens of countries, using its global distribution network and beloved brands like Oreo and Cadbury to push volume while raising prices faste...
Why It’s Moving

Mondelez is drawing a split but still supportive analyst read as cost pressure weighs on the outlook.
- Analysts have stayed broadly constructive on Mondelez, with consensus estimates still clustered around a mid-to-high $60s valuation range, suggesting the market sees the stock as fairly stable rather than a high-growth name.
- Recent target changes have been mixed: some firms trimmed their outlook on cautious consumer-staples assumptions and cocoa-cost pressure, while others kept outperform-style ratings, signaling confidence in Mondelez’s resilience.
- The biggest takeaway for investors is that the debate is less about near-term demand and more about margin pressure, input costs, and how much pricing power Mondelez can sustain in a softer macro backdrop.

CL faces downside pressure as analysts flag limited upside and valuation risk.
- No major company-specific news, earnings release, or macro catalyst appears in the last 7 days, so the move is being driven mainly by analyst caution rather than a fresh event.
- The bearish case centers on valuation: CL is trading close to its recent range while some broker forecasts still imply downside, signaling that expectations may already be stretched.
- The stock’s defensive consumer-staples profile is helping limit volatility, but the lack of a near-term catalyst means investors are focusing on slower growth and limited re-rating potential.

Mondelez is drawing a split but still supportive analyst read as cost pressure weighs on the outlook.
- Analysts have stayed broadly constructive on Mondelez, with consensus estimates still clustered around a mid-to-high $60s valuation range, suggesting the market sees the stock as fairly stable rather than a high-growth name.
- Recent target changes have been mixed: some firms trimmed their outlook on cautious consumer-staples assumptions and cocoa-cost pressure, while others kept outperform-style ratings, signaling confidence in Mondelez’s resilience.
- The biggest takeaway for investors is that the debate is less about near-term demand and more about margin pressure, input costs, and how much pricing power Mondelez can sustain in a softer macro backdrop.

CL faces downside pressure as analysts flag limited upside and valuation risk.
- No major company-specific news, earnings release, or macro catalyst appears in the last 7 days, so the move is being driven mainly by analyst caution rather than a fresh event.
- The bearish case centers on valuation: CL is trading close to its recent range while some broker forecasts still imply downside, signaling that expectations may already be stretched.
- The stock’s defensive consumer-staples profile is helping limit volatility, but the lack of a near-term catalyst means investors are focusing on slower growth and limited re-rating potential.
Investment Analysis

Mondelez
MDLZ
Pros
- Mondelez has strong pricing power and strategic cost controls, including efficient cocoa sourcing adjustments to manage tariff impacts.
- It is positioned for sustained long-term growth by expanding in emerging markets and shifting towards healthier product options.
- The company has scale advantages that support profitability even amid commodity cost volatility and inflation pressures.
Considerations
- Recent Q3 2025 results showed a revenue shortfall and margin pressure from historically high cocoa costs, causing a negative market reaction.
- Its stock price has declined significantly over the past year, reflecting concerns about ongoing cost inflation and macroeconomic risks.
- Sensitivity to commodity and tariff fluctuations poses risks to supply chain stability and profit margins, creating uncertainty.
Pros
- Colgate-Palmolive maintains a broad, well-established global brand presence with a diversified product portfolio in oral care and personal products.
- The company benefits from relatively stable demand and less commodity cost volatility compared to food-focused peers.
- It has demonstrated consistent profitability with efficient cost management and resilient cash flow generation.
Considerations
- Colgate-Palmolive has experienced stock underperformance compared to peers, impacted by modest organic growth challenges.
- Growth prospects may be limited by mature market exposure and competitive intensity in key categories like oral care.
- The company faces execution risks related to innovation pace and evolving consumer preferences in a crowded personal care market.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Buy MDLZ or CL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


